Table 2 Survey respondents answers to imaging scenarios (N = 33)
Imaging for PCa Patients | ||
|---|---|---|
Patient 1a: 67 year old otherwise healthy man newly diagnosed with low-risk prostate cancer (PSA level 5.2ng/ml, Gleason score 6 in 5/12 cores, clinical stage T1c, prostate volume 46 cc on TRUS). | ||
n | % | |
No imaging (GL concordant) | 30 | 91% |
MRI (GL concordant) | 3 | 9% |
Patient 1b: After reviewing treatment options, the patient described above (PSA level 5.2ng/ml, Gleason 6 in 5/12 cores, clinical stage T1c) is interested in active surveillance. | ||
n | % | |
No imaging (GL concordant) | 21 | 64% |
MRI (GL concordant) | 11 | 33% |
CT scan | 1 | 3% |
Patient 2: 64 year old otherwise healthy man newly diagnosed with low-intermediate-risk prostate cancer (PSA level 9.2ng/ml, Gleason score 3 + 4 in 3/12 cores, Gleason 6 in 2/12 cores; clinical stage T1c, prostate volume 53 cc on TRUS). | ||
n | % | |
No imaging (GL concordant) | 24 | 75% |
MRI (GL concordant) | 6 | 19% |
CT scan or bone scan | 2 | 6% |
Patient 3: 69 year old otherwise healthy man newly diagnosed with high-intermediate-risk prostate cancer (PSA level 11.1ng/ml, Gleason score 4 + 3 in 4/12 cores, Gleason 3 + 4 in in 2/12 cores; clinical stage T1c, prostate volume 47 cc on TRUS) | ||
n | % | |
No imaging | 5 | 15% |
MRI or CT or bone scan (GL concordant) | 28 | 85% |
Patient 4: 66 year old otherwise healthy man newly diagnosed with high-risk localized prostate cancer (PSA level 16.2ng/ml, Gleason score 4 + 4 in 5/12 cores, Gleason 4 + 3 in in 2/12 cores; clinical stage T2a, prostate volume 62 cc on TRUS) | ||
n | % | |
No imaging | 2 | 6% |
MRI or CT or bone scan (GL concordant) | 31 | 94% |
Imaging for AMH Patients | ||
Patient 5: 37 year old nonsmoking female with no significant past medical history referred to you for asymptomatic microscopic hematuria (7 erythrocytes/HPF on microscopic urinalysis). Urine culture negative. | ||
n | % | |
No imaging | 3 | 9% |
Renal ultrasound | 11 | 33% |
CT urogram or flexible cystoscopy (GL concordant) | 12 | 36% |
Repeat urinalysis* | 7 | 21% |
Patient 6: 40 year old nonsmoking male with no significant past medical history referred to you for asymptomatic microscopic hematuria (> 3 erythrocytes/HPF on two separate microscopic urinalysis). Urine culture negative. | ||
n | % | |
No imaging | 5 | 15% |
Renal ultrasound | 5 | 15% |
CT urogram or flexible cystoscopy (GL concordant) | 23 | 70% |
Patient 7: 62 year old nonsmoking female with no significant past medical history referred to you for asymptomatic microscopic hematuria (> 3 erythrocytes/HPF on one microscopic urinalysis). Urine culture negative. | ||
n | % | |
No imaging | 5 | 15% |
Renal ultrasound | 7 | 21% |
CT urogram or flexible cystoscopy (GL concordant) | 16 | 48% |
Repeat urinalysis* | 5 | 15% |